Economy on 25.04.2024...

Recovery stopped right away? Meta falls, despite solid figures...⤵️

Tuesday led us to believe that the correction, if it is one at all, has already come to an end and the recovery is underway. Economic data from the USA also look good and many investors were already very euphoric again.

Was that too early?

Was it just a fake breakout?

Was yesterday's setback too exaggerated?

These are questions that you always ask yourself. The stock market is not a one-way street. I stopped out a few shorts on Tuesday that would have made too much money yesterday or tonight. The stock market can be that simple :D

It's always good to have some cash in your portfolio for moments like this. It always lets you sleep well and the money management for the risk area in the portfolio has to be right. Let's see how the market continues today and how we go into the weekend. For now, let's take a look at tonight's figures.

$META
Meta Platforms
first quarter EPS of $4.71 beats analyst estimates of $4.32. Revenue of $36.46bn beats expectations of $36.14bn. Meta sees second quarter revenue of $36.5-39bn (consensus $38.25bn). Meta raises CAPEX outlook for FY 2024 from $30-37bn to $35-40bn. Active users increase by 7% but spending also increases by 6%. As a result, the outlook for Q2 is somewhat weaker.

$IBM
IBM
beats analyst estimates of $1.58 in the first quarter with earnings per share of $1.68. Revenue of $14.46 bn below expectations of $14.51 bn. IBM confirms guidance for 2024 and expects revenue growth in the mid-single digits. Still sees free cash flow of $12 billion.

$F
Ford Motor
First quarter earnings per share of $0.49 beat analyst estimates of $0.42. Revenue of $42.8bn below expectations of $42.94bn.

$CMG
Chipotle Mexican Grill
first quarter earnings per share of $13.37 beat analysts' estimates of $11.65. Sales of $2.7 billion beat expectations of $2.67 billion.

$WM
Waste Management Inc.
(Del.) first-quarter EPS of $1.75 beat analysts' estimates of $1.50. Revenue of $5.16 billion beat expectations of $5.21 billion.

$LRCX
Lam Research
third quarter EPS of $7.79 beats analysts' estimates of $7.29. Revenue of $3.79 billion beats expectations of $3.72 billion.

$NOW
ServiceNow
first quarter earnings per share of $3.41 beat analyst estimates of $3.15. Revenue of $2.6 billion beat expectations of $2.59 billion.

The trading day today will also have a lot to offer:

Economic data

08:00

DE: GfK consumer climate indicator April FORECAST: -26.0 points previously: -27.4 points

DE: Construction industry, new orders and sales, February

08:45

FR: Business Climate Index April PROGNOSIS: 103 previous: 102

14:30

US: GDP (1st release) 1Q annualized FORECAST: +2.4% yoy Q4: +3.4% yoy GDP deflator FORECAST: +3.0% yoy Q4: +1.6% yoy

• US: Initial jobless claims (week) FORECAST: 215,000 previous: 212,000

ex-dividend of individual stocks

RTL GROUP 2.75 EUR

Quarterly figures / Company dates USA / Asia

01:30 SK Hynix quarterly figures

07:00 Hyundai quarterly figures

12:30 Caterpillar | Merck & Co | Honeywell

13:00 American Airlines quarterly figures

14:00 Dow Inc quarterly figures

22:01 Microsoft | Intel quarterly figures

22:30 Alphabet | T-Mobile US quarterly figures

Quarterly figures / Company dates Europe

01:30 SK Hynix quarterly figures

06:30 BASF | Redcare Pharmacy | Equinor

06:30 Holcim Trading Update 1Q

07:00 Deutsche Bank | DWS Group | Hella | Hellofresh

07:00 Kion Group | Wacker Chemie | BNP Paribas | Takkt

07:00 Vossloh | STMicroelectronics Quarterly figures

07:15 Nestle 1Q sales

07:30 Aixtron | Atoss | Befesa | Delivery Hero | Symrise

07:30 Baader Bank | Drägerwerk | Pfeiffer Vacuum

07:30 SNP Schneider | Sanofi | Schneider Electric

07:30 Andritz | Adyen quarterly figures

08:00 DFV Deutsche Familienversicherung | LPKF Laser

08:00 Hermes International | Repsol

08:00 Astrazeneca | Barclays quarterly figures

09:00 KSB 1Q results

10:00 BASF | Hella | Munich Re | Schaeffler

10:00 Hamborner Reit AGM

14:30 Hochtief AGM

17:45 Vinci 1Q sales | Airbus quarterly figures

18:00 Flatexdegiro quarterly figures

18:00 Saint-Gobain Turnover 1Q

#meta
#microsoft
#ibm
#alphabet
#intel
#tmobile
#tmobileus
#quartalszahlen
#quartalsbericht
#aktien
#börse
#finanzen
#news
#nachrichten

Quarterly figures on 01.02.2023...

Figures interest and yield... today everything there

Today there was the FED interest rate decision and the FED increases, as expected by 25 basis points. In addition, the Fed says that further increases are necessary, but the pressure is taken out a bit, so you could count on 2 more increases until May, then they have reached their 5% and then it could possibly be over. I am curious...but now first of all the quarterly figures from today!

$META
Meta Platforms:

Missed analyst estimates of $2.26 in the fourth quarter with earnings per share of $1.76. Revenue of $32.17 billion above expectations of $31.53 billion. Meta expands buybacks by $40 billion.

$TMUS
T-Mobile US Inc:

fourth-quarter earnings per share of $1.18 beat analyst estimates of $1.07; Ebitda (adjusted) of $6.83 billion exceeded analyst estimates of $6.71 billion; revenue of $20.27 billion below expectations of $20.7 billion; in outlook for 2023, T-Mobile US expects Ebitda (adjusted) of $28.7 billion to $29.2 billion (analyst forecast: $29.3 billion), free cash flow of $13.1 billion to $13.6 billion (forecast: $13.6 billion), and capex of $9.4 billion to $9.7 billion (forecast: $10.3 billion).

$NOVN
Novartis:

Posts Q4 sales of $12.8 billion (analyst forecast: $13 billion), core EBIT of $4.03 billion (forecast: $3.8 billion) and core net income of $3.25 billion (forecast: $3 billion). In the 2023 outlook, sales are expected to grow in the low to mid-single digits; operating income is expected to grow in the mid-single digits. Sandoz spin-off still on track for second-half 2023, but shareholders are still expected to enjoy a higher dividend for the past year. This is to rise to 3.20 Swiss francs from 3.10 francs in 2021.

$NOVO B
Novo Nordisk:

Net income rose to 13.59 billion kroner from 10.89 billion kroner, thanks to strong demand for diabetes and obesity drugs, the company said. It beat the consensus forecast of 13.08 billion kroner by analysts surveyed by FactSet. Sales also exceeded analysts' expectations (47.26 billion kronor), growing 25 percent to 48.09 billion kronor. While revenue from drugs to treat diabetes and obesity rose sharply in some cases, insulin sales fell 12 percent. Novo Nordisk expects 2023 sales growth and operating profit growth in a range of 13 to 19 percent in local currencies. Nominal sales growth is expected to be about 4 percentage points below comparable growth, and reported operating profit growth about 5 percentage points below. Novo Nordisk proposed a final dividend of 8.15 kroner, which would bring the total dividend for 2022 to 12.40 kroner (previous year: 10.40).

#meta
#novonordisk
#novartis
#tmobileus
#inflation
#zinswende
#zinserhöhung
#powell
#fed

#quartalszahlen
#aktien
#boerse
#börse
#dividende
#dividenden
#news
#newsroom
#nachrichten
#investieren
#zinsen